HeartBeam Appoints Robert Eno As President
Senior Medical Technology Executive to Enhance Company's Strategic and Operations Capabilities
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector
HeartBeam Partners With Evolve Manufacturing To Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device
Partnership Positions AIMIGo for Early Market Testing in Q2 2023 After Expected FDA Clearance
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector
Alliance Global Partners Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $10
Alliance Global Partners analyst Ben Haynor initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy rating and announces Price Target of $10.
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart Attacks
HeartBeam Inc (NASDAQ: BEAT) announced that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended to detect heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office (USPTO).
New HeartBeam Patent For 12-Lead Electrocardiogram Smartwatch-Based Monitor Intended For Detection Of Heart Attacks And Complex Cardiac Arrhythmias
Patent Opens Pathway to Disruptive Ischemia and Arrhythmia Detection Product in Multi-billion Dollar Wearables Device Market
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers
Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers
Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
US Stocks Open Lower; Dow Drops Over 200 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Thursday.